Patients with active disease have autoantibodies to the enzyme transglutaminase 2 (TG2)4 of various isotypes in the blood (2), and IgA- and IgM- producing plasma cells specific for TG2 are abundantly present in small intestinal disease lesions (3). This evidence concerns the gene TGM2 and small intestine disorder.